{"nctId":"NCT00734578","briefTitle":"Efficacy and Safety of SPD503 in Combination With Psychostimulants","startDateStruct":{"date":"2008-09-02","type":"ACTUAL"},"conditions":["ADHD"],"count":461,"armGroups":[{"label":"SPD503-AM","type":"EXPERIMENTAL","interventionNames":["Drug: SPD503-AM"]},{"label":"SPD503-PM","type":"EXPERIMENTAL","interventionNames":["Drug: SPD503-PM"]},{"label":"Placebo","type":"PLACEBO_COMPARATOR","interventionNames":["Drug: Placebo"]}],"interventions":[{"name":"SPD503-AM","otherNames":["Intuniv"]},{"name":"SPD503-PM","otherNames":["Intuniv"]},{"name":"Placebo","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Healthy subjects with ADHD currently taking a stable dose of psychostimulant for at least 4 weeks\n* Aged 6-17 years with a sub-optimal\n* Partial response to stimulants\n* Subjects must be \\< 95th percentile for BMI with weight \\>= 55lbs and \\<= 176lbs","healthyVolunteers":false,"sex":"ALL","minimumAge":"6 Years","maximumAge":"17 Years","stdAges":["CHILD"]},"locations":{"multicenter":true},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Change From Baseline in Attention Deficit Hyperactivity Disorder Rating Scale-fourth Edition (ADHD-RS-IV) Total Score at Week 8 - Last Observation Carried Forward (LOCF)","description":"The ADHD-RS-IV consists of 18 items scored on a 4-point scale ranging from 0 (no symptoms) to 3 (severe symptoms) with total score ranging from 0 to 54.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-20.4","spread":"12.77"},{"groupId":"OG001","value":"-21.0","spread":"12.39"},{"groupId":"OG002","value":"-16.0","spread":"11.77"}]}]}]},{"type":"SECONDARY","title":"Percentage of Participants With Improvement on Clinical Global Impression-Improvement (CGI-I) at Week 8 - LOCF","description":"Clinical Global Impression-Improvement (CGI-I) consists of a 7-point scale ranging from 1 (very much improved) to 7 (very much worse). Improvement is defined as a score of 1 (very much improved) or 2 (much improved) on the scale.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"70.5","spread":null},{"groupId":"OG001","value":"74.3","spread":null},{"groupId":"OG002","value":"57.9","spread":null}]}]}]},{"type":"SECONDARY","title":"Assessment of Clinical Global Impression-Severity of Illness (CGI-S) at Week 8 - LOCF","description":"CGI-S assesses the severity of the subject's condition on a 7-point scale ranging from 1 (normal, not at all ill) to 7 (among the most extremely ill)","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"22.8","spread":null},{"groupId":"OG001","value":"25.0","spread":null},{"groupId":"OG002","value":"15.1","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"19.5","spread":null},{"groupId":"OG001","value":"26.4","spread":null},{"groupId":"OG002","value":"17.8","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"34.2","spread":null},{"groupId":"OG001","value":"26.4","spread":null},{"groupId":"OG002","value":"28.9","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"16.1","spread":null},{"groupId":"OG001","value":"16.2","spread":null},{"groupId":"OG002","value":"27.0","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"6.0","spread":null},{"groupId":"OG001","value":"5.4","spread":null},{"groupId":"OG002","value":"9.2","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1.3","spread":null},{"groupId":"OG001","value":"0.7","spread":null},{"groupId":"OG002","value":"2.0","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.0","spread":null},{"groupId":"OG001","value":"0.0","spread":null},{"groupId":"OG002","value":"0.0","spread":null}]}]}]},{"type":"SECONDARY","title":"Change From Baseline in Conners' Global Index - Parent (CGI-P) Total Score at Week 8 - LOCF: Morning Assessment (Before School)","description":"The index contains 10 items. Each item on the scale is scored from a range of 0 (reflecting never, seldom) to 3 (reflecting very often, very frequent) with total scores ranging from 0 to 30.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-8.4","spread":"7.27"},{"groupId":"OG001","value":"-9.6","spread":"7.68"},{"groupId":"OG002","value":"-6.9","spread":"6.89"}]}]}]},{"type":"SECONDARY","title":"Change From Baseline in Conners' Global Index - Parent (CGI-P) Total Score at Week 8 - LOCF: Evening Assessment (Before Bedtime)","description":"The index contains 10 items. Each item on the scale is scored from a range of 0 (reflecting never, seldom) to 3 (reflecting very often, very frequent) with total scores ranging from 0 30.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-8.2","spread":"7.79"},{"groupId":"OG001","value":"-8.8","spread":"7.21"},{"groupId":"OG002","value":"-6.0","spread":"6.84"}]}]}]},{"type":"SECONDARY","title":"Percentage of Participants With Improvement on Parent Global Assessment (PGA) at Week 8 - LOCF","description":"Parent Global Assessment (PGA) consists of a 7-point scale ranging from 1 (very much improved) to 7 (very much worse). Improvement is defined as a score of 1 (very much improved) or 2 (much improved) on the scale.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"69.8","spread":null},{"groupId":"OG001","value":"67.7","spread":null},{"groupId":"OG002","value":"47.5","spread":null}]}]}]},{"type":"SECONDARY","title":"Change From Baseline in the Oppositional Subscale of the Conners' Parent Rating Scale-Revised Long Form (CPRS-R:L) Score at Week 8 - LOCF","description":"The oppositional subscale of the CPRS-R:L contains 10 items designed to reflect criteria for oppositional defiance disorder (ODD). Each item is scored on a range from 0 (not true at all) to 3 (very much true) with total scores ranging from 0 to 30. Higher scores are reflective of more severe symptoms.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-6.6","spread":"6.97"},{"groupId":"OG001","value":"-6.3","spread":"7.05"},{"groupId":"OG002","value":"-4.2","spread":"6.79"}]}]}]},{"type":"SECONDARY","title":"Change From Baseline in Before School Functioning Questionnaire (BSFQ) at Week 8 - LOCF","description":"This scale was designed to assess symptoms of ADHD that typically occur in the morning. The BSFQ consists of two components. The first, a 20-item scale with ratings from 0 (none) to 3 (severe) with a range of 0-60 followed by two questions answered with duration of time (in minutes). The second, a 14-item scale with ratings from 0 (no) to 2 (a lot) with a range of 0-28. The results reported here are from the 20-item scale. Lower scores are better.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-16.7","spread":"13.87"},{"groupId":"OG001","value":"-16.7","spread":"13.45"},{"groupId":"OG002","value":"-11.5","spread":"13.45"}]}]}]},{"type":"SECONDARY","title":"Post Sleep Questionnaire (PSQ) Quality of Sleep at Week 8 - LOCF","description":"Post Sleep Questionnaire (PSQ) overall rating of quality of sleep. There are 5 rating responses ranging from very poor to very good. No numbers are associated with the rating responses.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0.7","spread":null},{"groupId":"OG001","value":"0.7","spread":null},{"groupId":"OG002","value":"0.0","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"6.7","spread":null},{"groupId":"OG001","value":"6.8","spread":null},{"groupId":"OG002","value":"3.3","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"26.8","spread":null},{"groupId":"OG001","value":"29.7","spread":null},{"groupId":"OG002","value":"33.3","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"40.3","spread":null},{"groupId":"OG001","value":"41.2","spread":null},{"groupId":"OG002","value":"40.5","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"25.5","spread":null},{"groupId":"OG001","value":"21.6","spread":null},{"groupId":"OG002","value":"22.9","spread":null}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":1,"n":150},"commonTop":["Headache","Somnolence","Upper respiratory tract infection","Fatigue","Insomnia"]}}}